| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.9 |
| mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |